BioAge Labs, Inc.

ACTIVE

1445 S 50TH St Ste A, 加利福尼亚州康特拉科斯塔县, California, United Stateswww.bioagelabs.comHolding101–250 employeesEstablished: 2015-01-01

Also known as:

BioAge

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2015

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

85.7%

Phase 1

14.3%

Trial Status Distribution

Active, not recruiting

14.3%

Completed

14.3%

Recruiting

14.3%

Terminated

28.6%

Withdrawn

28.6%

Clinical Trials

Trials sponsored by this organization (7)

A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema

Phase 2

Recruiting

interventional

Aug 2026180 participants

A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Participants With Obesity and Cardiovascular Risk Factors

Phase 2

Active, not recruiting

interventional

Jun 2026160 participants

Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared With Tirzepatide Alone in Participants With Obesity Aged 55 Years and Over

Phase 2

Terminated

interventional

Jun 2024204 participants

Pharmacokinetics Study of Azelaprag (BGE-105) in Older Adult Healthy Volunteers

Phase 1

Completed

interventional

Nov 202316 participants

Study to Evaluate Efficacy and Safety of BGE-117 in Moderately to Severely Anemic Older Individuals After Major Hip Surgery

Study to Evaluate Efficacy and Safety of BGE-117 in the Treatment of Anemia of Aging

Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure

Phase 2

Terminated

interventional

Mar 2021194 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations